Published in
Taylor and Francis Group, Expert Opinion on Therapeutic Targets, 6(26), p. 557-573, 2022
DOI: 10.1080/14728222.2022.2084380
Links
Tools
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets
Journal article published in 2022 by
Alberto Zambelli,
Riccardo Sgarra,
Rita De Sanctis,
Elisa Agostinetto 
,
Armando Santoro,
Guidalberto Manfioletti
,
Armando Santoro,
Guidalberto Manfioletti
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 